U01CA247439
Cooperative Agreement
Overview
Grant Description
Deciphering clonal evolution in hereditary renal cell carcinomas.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
United Kingdom
Geographic Scope
Foreign
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/24 to 08/31/25 and the total obligations have increased 253% from $317,425 to $1,121,209.
The Francis Crick Institute was awarded
Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas
Cooperative Agreement U01CA247439
worth $1,121,209
from National Cancer Institute in September 2020 with work to be completed primarily in United Kingdom.
The grant
has a duration of 5 years and
was awarded through assistance program 93.395 Cancer Treatment Research.
The Cooperative Agreement was awarded through grant opportunity Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional).
Status
(Complete)
Last Modified 9/5/24
Period of Performance
9/4/20
Start Date
8/31/25
End Date
Funding Split
$1.1M
Federal Obligation
$0.0
Non-Federal Obligation
$1.1M
Total Obligated
Activity Timeline
Transaction History
Modifications to U01CA247439
Additional Detail
Award ID FAIN
U01CA247439
SAI Number
U01CA247439-13313962
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Non-Domestic (Non-U.S.) Entity
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
VRHEWNUW2PS5
Awardee CAGE
U0Z74
Performance District
Not Applicable
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $926,968 | 100% |
Modified: 9/5/24